Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions |
umls-concept:C0016884,
umls-concept:C0021246,
umls-concept:C0025344,
umls-concept:C0033414,
umls-concept:C0033554,
umls-concept:C0034693,
umls-concept:C0034721,
umls-concept:C0034897,
umls-concept:C0038358,
umls-concept:C0041582,
umls-concept:C0043240,
umls-concept:C0087111,
umls-concept:C0205265,
umls-concept:C0205322,
umls-concept:C0442805,
umls-concept:C0680727,
umls-concept:C1555582,
umls-concept:C1561960,
umls-concept:C1948053,
umls-concept:C2347804
|
| pubmed:issue |
10
|
| pubmed:dateCreated |
1996-11-27
|
| pubmed:abstractText |
The study was performed to examine whether indomethacin administered during the initial period of acetic acid-induced gastric ulcer healing affects future ulcer recurrence. Gastric ulcers were produced in rats by subserosal injection of acetic acid. Indomethacin (1 mg/kg/day, orally) administered either alone or concomitant with ornoprostil (50 micrograms/kg/day, orally) was started on the fourth day and continued for 56 days. In rats whose ulcer healed at the 90th day after production of ulcer, endoscopy was done every 30 days to examine recurrence of ulcer. Gastric specimens were obtained 10, 30, 60, 90, and 240 days after ulcer production for histology, to quantitate the height of regenerated mucosa, thickness of fibrous tissue, degree of polymorphonuclear cell infiltration, and PAS-positive cells. Cumulative ulcer recurrence rate was significantly higher in rats initially treated with indomethacin than in controls. Increased polymorphonuclear cell infiltration was the major histologic abnormality persisting after cessation of indomethacin. Ornoprostil reversed these abnormalities caused by indomethacin. In conclusion, the administration of indomethacin during the initial period of the ulcer healing promoted persistent polymorphonuclear cell infiltration and increased ulcer recurrence rates, possibly via a prostaglandin-dependent mechanism.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Oct
|
| pubmed:issn |
0163-2116
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
41
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
2055-61
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:8888721-Alprostadil,
pubmed-meshheading:8888721-Animals,
pubmed-meshheading:8888721-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:8888721-Dinoprostone,
pubmed-meshheading:8888721-Indomethacin,
pubmed-meshheading:8888721-Male,
pubmed-meshheading:8888721-Neutrophils,
pubmed-meshheading:8888721-Rats,
pubmed-meshheading:8888721-Rats, Wistar,
pubmed-meshheading:8888721-Recurrence,
pubmed-meshheading:8888721-Stomach Ulcer
|
| pubmed:year |
1996
|
| pubmed:articleTitle |
Indomethacin treatment during initial period of acetic acid-induced rat gastric ulcer healing promotes persistent polymorphonuclear cell-infiltration and increases future ulcer recurrence. Possible mediation of prostaglandins.
|
| pubmed:affiliation |
Third Department of Internal Medicine, Osaka City University Medical School, Japan.
|
| pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|